Watchlist Price Alert

Aclaris Therapeutics Inc. (ACRS)

NASDAQ: ACRS · Real-Time Price · USD

1.44

0.00 (0.00%)

At close: Jun 17, 2025, 12:38 PM

Aclaris Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-132.06M	-88.48M	-86.91M	-90.86M	-51.02M	-161.35M	-132.74M	-68.52M	-48.08M
Depreciation & Amortization	807K	863K	797K	923K	1.32M	6.41M	1.88M	402K	120K
Stock-Based Compensation	10.86M	20.54M	15.04M	14.06M	11.21M	16.18M	20.05M	14.43M	6.1M
Other Working Capital	15.13M	10.68M	-1.7M	-5.15M	-2.04M	661K	6.75M	-3.7M	2.44M
Other Non-Cash Items	89.41M	-20.27M	4.7M	24.34M	2.39M	734K	555K	10.67M	2.78M
Deferred Income Tax	n/a	-367K	n/a	752K	-182K	44.29M	n/a	-1.84M	216K
Change in Working Capital	10.92M	9.39M	-1.2M	-1.34M	-2.36M	-2.7M	9.44M	865K	4.25M
Operating Cash Flow	-20.07M	-78.33M	-67.57M	-52.13M	-38.63M	-96.44M	-100.81M	-54.66M	-34.6M
Capital Expenditures	-121K	-1.31M	-605K	-308K	-453K	-1.61M	-1.36M	-1.24M	-232K
Cash Acquisitions	n/a	n/a	-13.23M	167.32M	-6.84M	34.19M	-67.12M	-9.65M	n/a
Purchase of Investments	-119.98M	-135.68M	-164.75M	-235.15M	-47.71M	-137.38M	-161.6M	-197.34M	-148.76M
Sales Maturities Of Investments	86.14M	183.2M	177.99M	67.83M	54.55M	210.49M	239.44M	152.53M	87.09M
Other Investing Acitivies	-35.81M	n/a	13.23M	-167.32M	6.84M	34.19M	77.84M	-44.81M	-61.67M
Investing Cash Flow	-69.77M	46.22M	12.63M	-167.63M	6.39M	105.68M	9.37M	-55.69M	-61.9M
Debt Repayment	n/a	n/a	n/a	-11.48M	10.78M	-30.52M	29.26M	-78K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-409K	-8K	123K	-1.67M	7.6M	207K	-1.21M	235K	121K
Financial Cash Flow	74.54M	26.71M	72.87M	225.05M	18.37M	-30.32M	128.26M	100.39M	116.83M
Net Cash Flow	-15.31M	-5.4M	17.93M	5.29M	-13.87M	-21.08M	36.82M	-9.97M	20.32M
Free Cash Flow	-20.2M	-79.63M	-68.17M	-52.44M	-39.09M	-98.06M	-102.17M	-55.9M	-34.84M